More Resources. More Technology. Same Great Service.
What you can Expect
Everything You Need
CleveMed is now part of Beacon Biosignals. Here is what this means for your practice and your patients.
No Service Disruption
SleepView® devices and SleepView℠ Direct will continue operating exactly as before. No action required.
Expanded Capabilities
Backed by $132M in funding and AI platform, expect a broader portfolio of diagnostic tools, enhanced integrations, and new service offerings over time.
Contracts & Billing Unchanged
Your existing contracts, pricing, and billing remain fully in place. We will contact you directly as new offerings become available which may require an update.
Same Support Team
Your dedicated customer experience contacts are still here now backed by the full resources of Beacon Biosignals. We are growing our team to align with our expanding customer base.
Same Accessory Kits
When ordering accessory kits for on-site dispensing, you may notice new branding or labeling as we transition. Rest assured the accessories inside the packaging will remain the same.
CleveMed Website
As CleveMed becomes part of Beacon Biosignals, our product information and resources pages can be found on beacon.bio.
Tradeshows and Conferences
Looking for CleveMed? We’ll still be there, now under Beacon Biosignals. Visit us at SLEEP 2026 in Booth 1055.
LinkedIn Company Page
The CleveMed company page will remain active on LinkedIn but now under the Beacon Biosignals brand. Same content. New look and feel.
Contact, Sales & Support
Your Contact Information Stays the Same
1.877.253.8363
216.791.6720 (Option 2)
FAQ
Your Questions, Answered
What exactly has changed with the CleveMed and Beacon Biosignals merger?
Do I need to do anything differently to continue using my SleepView services?
Will my contract, pricing, or billing change?
Can I still reach my same CleveMed support contacts?
Will my SleepView Web Portal login or URL change?
Will my SleepView Direct shipments continue on the same schedule?
What benefits does this merger bring to my practice?
Will CleveMed's accreditations and certifications be maintained?
How can I submit a support ticket or track an existing case?
Who do I contact if I have questions not covered here?
News & Resources
Latest Research from Beacon
Learn how Beacon Biosignals is shaping the future of brain health through leading research and scientific discovery.
Announcement
Beacon Biosignals Completes Strategic Transaction to Acquire CleveMed
CleveMed and Beacon Biosignals officially unite under one brand to deliver the most complete sleep health platform, from AI-powered EEG biomarkers to accessible home sleep testing nationwide.
Apr, 2026
Press release
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
Funding will accelerate commercialization of the Waveband EEG platform and expand Beacon's reach in global pharmaceutical clinical trials, with benefits flowing directly to CleveMed diagnostic services.
Apr, 2026
Recognition
Beacon Named in Fast Company's Most Innovative Companies of 2026
Beacon Biosignals was recognized for its AI-driven approach to neurotechnology and the measurable impact of sleep EEG biomarkers in pharmaceutical drug development.
Mar, 2026
Funding
CleveMed's Parent Company Secures $86M for AI-Driven Brain Health Insights
Beacon Biosignals completed an $86M funding round to accelerate AI technologies for brain health, directly strengthening CleveMed's ability to expand reach and integrate next-generation diagnostics.
Nov, 2025
Announcement
Beacon Biosignals Completes Strategic Acquisition of CleveMed
Beacon Biosignals announced the completion of its strategic acquisition of CleveMed, strengthening capabilities across home sleep testing, EEG biomarkers, and AI-driven neurotechnology.
Apr, 2025
Event
Visit Beacon Biosignals at SLEEP 2026 — Booth #1055
For the first time as a unified company, Beacon Biosignals showcases the complete platform at SLEEP 2026, including SleepView HSAT diagnostics, Waveband EEG, and SleepView Direct logistics.
Jun, 2026